Company / Free Cash Flow
Zimmer Biomet Free Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
$1.5B
FY2025
5-year range
$1.2B / $1.5B
FY2021-FY2025
Trend
+13.7%
vs FY2024
Sector context
#20 of 151
Health Care
What the data says
Zimmer Biomet's free cash flow of $1.5B is higher than 87% of companies in the Health Care sector (FY2025). Free Cash Flow has increased for 3 consecutive years, from $1.2B in FY2022 to $1.5B in FY2025.
Based on SEC 10-K filings.
$1.5B in FY2025 with a 5-year CAGR of +6.2%. Top quartile in the Health Care sector.
Improved from $1.3B to $1.5B over the past 2 years.
Health Care sector context is included.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- +8.0%
- 5-Year CAGR
- +6.2%
- 10-Year CAGR
- -
Sector benchmark
Top 13% in Health CareTop 13% of 151This company $1.5B Sector average $779.8M
▼
+88.8% above sector average
Key checks
Key Insights
- Zimmer Biomet's free cash flow has grown for 3 consecutive years.
- 5-year CAGR of +6.2%, indicating consistent growth.
- In FY2025, free cash flow increased 13.7% year-over-year.
- Ranks #20 out of 151 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.5B | +13.7% |
| FY2024 | $1.3B | +0.4% |
| FY2023 | $1.3B | +10.5% |
| FY2022 | $1.2B | -13.8% |
| FY2021 | $1.4B | +24.1% |
| FY2020 | $1.1B | -23.4% |
| FY2019 | $1.4B | -1.5% |
| FY2018 | $1.4B | +1.5% |
| FY2017 | $1.4B | +55.8% |
| FY2016 | $915.6M | +34.2% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026